Activating DNA demethylation with clozapine and olanzapine with VPA (histone deacetylase inhibitor, HDAC) may be considered a promising therapeutic strategy to normalize GABAergic promoter hypermethylation and decreased GABAergic gene expression detected in postmortem brains of patients with schizophrenia and bipolar disorder. Here, HDAC9 is linked to bipolar disorder.